Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.07 USD | +2.93% | +1.13% | +148.92% |
04-10 | Arcutis Biotherapeutics, Inc. Announces Chief Financial Officer Changes | CI |
03-18 | Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P Biotechnology Select Industry Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+148.92% | 906M | |
+4.50% | 109B | |
+11.43% | 105B | |
+0.70% | 22.25B | |
-11.55% | 22.09B | |
-7.73% | 18.68B | |
-38.36% | 17.58B | |
-10.50% | 16.85B | |
+4.43% | 13.76B | |
+36.89% | 12.46B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Morgan Stanley Adjusts Price Target on Arcutis Biotherapeutics to $10 From $45, Maintains Overweight Rating